These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1266661)

  • 1. Plasma renin activity and hypertensive organ manifestations in 50-year-old males.
    Berglund G; Aurell M; Wikstrand J; Wallentin I
    Acta Med Scand; 1976; 199(4):243-9. PubMed ID: 1266661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function in normo- and hypertensive 50-year-old males.
    Berglund G; Aurell M; Wilhelmsen L
    Acta Med Scand; 1976; 199(1-2):25-32. PubMed ID: 1251770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary noradrenaline excretion and renal function in normal and hypertensive 50-year-old men.
    Berglund G; Tibblin G; Aurell M
    Clin Sci Mol Med; 1975 Nov; 49(5):485-93. PubMed ID: 1192707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive hormones in the renal response to systemic sepsis.
    Cumming AD; Driedger AA; McDonald JW; Lindsay RM; Solez K; Linton AL
    Am J Kidney Dis; 1988 Jan; 11(1):23-32. PubMed ID: 3276170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-modulating hypertension: evidence for the involvement of kallikrein/kinin activity associated with overactivity of the renin-angiotensin system. Successful blood pressure control during long-term Na+ restriction.
    Sanchez R; Gimenez MI; Ramos F; Baglivo H; Ramirez AJ
    J Hypertens; 1996 Nov; 14(11):1287-91. PubMed ID: 8934356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of the renin-angiotensin system in sodium regulation in essential hypertension.
    Kawabe H; Furukawa T; Takenaka T; Saito I; Saruta T
    Am J Hypertens; 1991 Feb; 4(2 Pt 1):119-25. PubMed ID: 1826997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
    Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
    Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathoinhibitory Effect of Radiofrequency Renal Denervation in Spontaneously Hypertensive Rats With Established Hypertension.
    Gao J; Kerut EK; Smart F; Katsurada A; Seth D; Navar LG; Kapusta DR
    Am J Hypertens; 2016 Dec; 29(12):1394-1401. PubMed ID: 27538721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Bandiera F; Manunta P; Rubattu S; Rappelli A
    J Hypertens; 1987 Oct; 5(5):581-6. PubMed ID: 2448367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dietary potassium in the hyperaldosteronism and hypertension of the remnant kidney model.
    Ibrahim HN; Hostetter TH
    J Am Soc Nephrol; 2000 Apr; 11(4):625-631. PubMed ID: 10752521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium excretion and sympathetic activity in relation to severity of hypertension.
    Berglund G; Wikstrand J; Ljungman S; Hartford M; Wilhelmsen L
    Contrib Nephrol; 1977; 8():135-41. PubMed ID: 891209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive and renal effects of isradipine in essential hypertension: focus on renin system activity.
    Allikmets K; Parik T; Teesalu R
    Angiology; 1997 Nov; 48(11):977-83. PubMed ID: 9373050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of plasma renin activity in chronic stable renal disease.
    Kahn T; Mohammad G; Bornia ME; Stein RM; Krakoff LR
    J Lab Clin Med; 1975 Apr; 85(4):637-44. PubMed ID: 1120931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous calcium infusion on indices of activity of the parathyroid glands and on urinary calcium and sodium excretion in normotensive and hypertensive subjects.
    Papagalanis N; Kourti A; Tolis A; Skopelitis P; Karabatsos A; Kostoyanni G; Gennadiou M; Elisaf M; Mountokalakis T
    Am J Hypertens; 1993 Jan; 6(1):59-65. PubMed ID: 8427663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension.
    Herlitz H; Palmgren E; Widgren B; Aurell M
    Clin Sci (Lond); 2005 Sep; 109(3):311-7. PubMed ID: 15901242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic responses in labile hypertension.
    Luft FC; Grim CE; Fineberg NS; Henry DP; Weinberger MH
    Am J Med Sci; 1982; 283(3):119-28. PubMed ID: 7044124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between sodium clearance, plasma renin activity, plasma aldosterone, renal hemodynamics and blood pressure in essential hypertension.
    Reubi FC; Weidmann P
    Clin Exp Hypertens (1978); 1980; 2(3-4):593-612. PubMed ID: 7000463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Extremely Low Birth Weight Predispose to Low-Renin Hypertension?
    Raaijmakers A; Zhang ZY; Claessens J; Cauwenberghs N; van Tienoven TP; Wei FF; Jacobs L; Levtchenko E; Pauwels S; Kuznetsova T; Allegaert K; Staessen JA
    Hypertension; 2017 Mar; 69(3):443-449. PubMed ID: 28115515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin inhibition improves pressure natriuresis in essential hypertension.
    Paassen PV; Zeeuw D; Jong PE; Navis G
    J Am Soc Nephrol; 2000 Oct; 11(10):1813-1818. PubMed ID: 11004211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A
    Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.